Altered expression of insulin-like growth factor II receptor in human pancreatic cancer

Toshiyuki Ishiwata, Uwe Bergmann, Marko Kornmann, Martha Lopez, Hans G. Beger, Murray Korc

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

The insulin-like growth factor-II (IGF-II) receptor (IGF-IIR) is a single-chain transmembrane protein identical to the mannose-6-phosphate receptor. In the present study we examined IGF-IIR expression in normal and cancerous human pancreatic tissues. In the normal pancreas, moderately strong IGF-IIR immunoreactivity was present in the cytoplasm of islet cells, and mild cytoplasmic immunoreactivity was evident occasionally in ductal and acinar cells. Some ductal cells also exhibited nuclear IGF-IIR immunoreactivity. In the pancreatic cancers, regions of strong IGF-IIR immunoreactivity were present in the duct-like cancer cells within the tumor mass, often exhibiting nuclear localization. Expression of IGF-IIR mRNA in the cancer cells was confirmed by in situ hybridization. By comparison with normal pancreatic tissues, 7 of 12 pancreatic cancers exhibited a 5.6-fold increase in IGF-IIR mRNA levels, whereas in 3 cancers the IGF-IIR transcript was below the level of detection. Furthermore, all six tested cultured human pancreatic cancer cell lines expressed the IGF-IIR mRNA transcript. Our data indicate that IGF-IIR is overexpressed in a significant number of human pancreatic cancers, where it has a tendency to localize in the nucleus, and raise the possibility that IGF-IIR may contribute to the pathobiology of pancreatic cancer.

Original languageEnglish (US)
Pages (from-to)367-373
Number of pages7
JournalPancreas
Volume15
Issue number4
StatePublished - Nov 1997
Externally publishedYes

Fingerprint

IGF Type 2 Receptor
Insulin-Like Growth Factor II
Pancreatic Neoplasms
Messenger RNA
Neoplasms
Acinar Cells
Islets of Langerhans
In Situ Hybridization
Pancreas
Cytoplasm

Keywords

  • Altered expression
  • Human pancreatic cancer
  • Insulin-like growth factor II receptor

ASJC Scopus subject areas

  • Gastroenterology
  • Endocrinology

Cite this

Ishiwata, T., Bergmann, U., Kornmann, M., Lopez, M., Beger, H. G., & Korc, M. (1997). Altered expression of insulin-like growth factor II receptor in human pancreatic cancer. Pancreas, 15(4), 367-373.

Altered expression of insulin-like growth factor II receptor in human pancreatic cancer. / Ishiwata, Toshiyuki; Bergmann, Uwe; Kornmann, Marko; Lopez, Martha; Beger, Hans G.; Korc, Murray.

In: Pancreas, Vol. 15, No. 4, 11.1997, p. 367-373.

Research output: Contribution to journalArticle

Ishiwata, T, Bergmann, U, Kornmann, M, Lopez, M, Beger, HG & Korc, M 1997, 'Altered expression of insulin-like growth factor II receptor in human pancreatic cancer', Pancreas, vol. 15, no. 4, pp. 367-373.
Ishiwata T, Bergmann U, Kornmann M, Lopez M, Beger HG, Korc M. Altered expression of insulin-like growth factor II receptor in human pancreatic cancer. Pancreas. 1997 Nov;15(4):367-373.
Ishiwata, Toshiyuki ; Bergmann, Uwe ; Kornmann, Marko ; Lopez, Martha ; Beger, Hans G. ; Korc, Murray. / Altered expression of insulin-like growth factor II receptor in human pancreatic cancer. In: Pancreas. 1997 ; Vol. 15, No. 4. pp. 367-373.
@article{e37c176a387f42d29c534617563bee1c,
title = "Altered expression of insulin-like growth factor II receptor in human pancreatic cancer",
abstract = "The insulin-like growth factor-II (IGF-II) receptor (IGF-IIR) is a single-chain transmembrane protein identical to the mannose-6-phosphate receptor. In the present study we examined IGF-IIR expression in normal and cancerous human pancreatic tissues. In the normal pancreas, moderately strong IGF-IIR immunoreactivity was present in the cytoplasm of islet cells, and mild cytoplasmic immunoreactivity was evident occasionally in ductal and acinar cells. Some ductal cells also exhibited nuclear IGF-IIR immunoreactivity. In the pancreatic cancers, regions of strong IGF-IIR immunoreactivity were present in the duct-like cancer cells within the tumor mass, often exhibiting nuclear localization. Expression of IGF-IIR mRNA in the cancer cells was confirmed by in situ hybridization. By comparison with normal pancreatic tissues, 7 of 12 pancreatic cancers exhibited a 5.6-fold increase in IGF-IIR mRNA levels, whereas in 3 cancers the IGF-IIR transcript was below the level of detection. Furthermore, all six tested cultured human pancreatic cancer cell lines expressed the IGF-IIR mRNA transcript. Our data indicate that IGF-IIR is overexpressed in a significant number of human pancreatic cancers, where it has a tendency to localize in the nucleus, and raise the possibility that IGF-IIR may contribute to the pathobiology of pancreatic cancer.",
keywords = "Altered expression, Human pancreatic cancer, Insulin-like growth factor II receptor",
author = "Toshiyuki Ishiwata and Uwe Bergmann and Marko Kornmann and Martha Lopez and Beger, {Hans G.} and Murray Korc",
year = "1997",
month = "11",
language = "English (US)",
volume = "15",
pages = "367--373",
journal = "Pancreas",
issn = "0885-3177",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Altered expression of insulin-like growth factor II receptor in human pancreatic cancer

AU - Ishiwata, Toshiyuki

AU - Bergmann, Uwe

AU - Kornmann, Marko

AU - Lopez, Martha

AU - Beger, Hans G.

AU - Korc, Murray

PY - 1997/11

Y1 - 1997/11

N2 - The insulin-like growth factor-II (IGF-II) receptor (IGF-IIR) is a single-chain transmembrane protein identical to the mannose-6-phosphate receptor. In the present study we examined IGF-IIR expression in normal and cancerous human pancreatic tissues. In the normal pancreas, moderately strong IGF-IIR immunoreactivity was present in the cytoplasm of islet cells, and mild cytoplasmic immunoreactivity was evident occasionally in ductal and acinar cells. Some ductal cells also exhibited nuclear IGF-IIR immunoreactivity. In the pancreatic cancers, regions of strong IGF-IIR immunoreactivity were present in the duct-like cancer cells within the tumor mass, often exhibiting nuclear localization. Expression of IGF-IIR mRNA in the cancer cells was confirmed by in situ hybridization. By comparison with normal pancreatic tissues, 7 of 12 pancreatic cancers exhibited a 5.6-fold increase in IGF-IIR mRNA levels, whereas in 3 cancers the IGF-IIR transcript was below the level of detection. Furthermore, all six tested cultured human pancreatic cancer cell lines expressed the IGF-IIR mRNA transcript. Our data indicate that IGF-IIR is overexpressed in a significant number of human pancreatic cancers, where it has a tendency to localize in the nucleus, and raise the possibility that IGF-IIR may contribute to the pathobiology of pancreatic cancer.

AB - The insulin-like growth factor-II (IGF-II) receptor (IGF-IIR) is a single-chain transmembrane protein identical to the mannose-6-phosphate receptor. In the present study we examined IGF-IIR expression in normal and cancerous human pancreatic tissues. In the normal pancreas, moderately strong IGF-IIR immunoreactivity was present in the cytoplasm of islet cells, and mild cytoplasmic immunoreactivity was evident occasionally in ductal and acinar cells. Some ductal cells also exhibited nuclear IGF-IIR immunoreactivity. In the pancreatic cancers, regions of strong IGF-IIR immunoreactivity were present in the duct-like cancer cells within the tumor mass, often exhibiting nuclear localization. Expression of IGF-IIR mRNA in the cancer cells was confirmed by in situ hybridization. By comparison with normal pancreatic tissues, 7 of 12 pancreatic cancers exhibited a 5.6-fold increase in IGF-IIR mRNA levels, whereas in 3 cancers the IGF-IIR transcript was below the level of detection. Furthermore, all six tested cultured human pancreatic cancer cell lines expressed the IGF-IIR mRNA transcript. Our data indicate that IGF-IIR is overexpressed in a significant number of human pancreatic cancers, where it has a tendency to localize in the nucleus, and raise the possibility that IGF-IIR may contribute to the pathobiology of pancreatic cancer.

KW - Altered expression

KW - Human pancreatic cancer

KW - Insulin-like growth factor II receptor

UR - http://www.scopus.com/inward/record.url?scp=0030816910&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030816910&partnerID=8YFLogxK

M3 - Article

VL - 15

SP - 367

EP - 373

JO - Pancreas

JF - Pancreas

SN - 0885-3177

IS - 4

ER -